Epstein–Barr Virus Monitoring after an Allogeneic Hematopoietic Stem Cell Transplant: Review of the Recent Data and Current Practices in Canada

Epstein–Barr Virus Monitoring after an Allogeneic Hematopoietic Stem Cell Transplant: Review of the Recent Data and Current Practices in Canada

Epstein–Barr virus-related post-transplantation lymphoproliferative disorder (EBV-PTLD) is a serious complication following hematopoietic stem cell transplantation (HSCT). A pre-emptive strategy using rituximab, which aims to manage patients early at the time of EBV reactivation to avoid PTLD, has b...

Full description

Bibliographic Details
Main Authors: Claire Ratiu, Simon F. Dufresne, Stéphanie Thiant, Jean Roy
Format: Article
Language:English
Published: MDPI AG 2024-05-01
Series:Current Oncology
Subjects:
rituximab
pre-emptive treatment
risk factors
Epstein–Barr virus
viral reactivation
post-transplant lymphoproliferative disorder
Online Access:https://www.mdpi.com/1718-7729/31/5/211

Internet

https://www.mdpi.com/1718-7729/31/5/211

Similar Items